Bose and Lexie Hearing Partner on Self-Fitting Hearing Aids

This partnership brings Bose’s self-fitting hearing aid technology to the Lexie Hearing product line

Image credit: Lexie Hearing

Bose Corporation and Lexie Hearing, a direct-to-consumer hearing aid provider in the United States, announced a partnership to bring Bose’s self-fitting hearing aid technology to the Lexie Hearing product line. The new Lexie B1 Hearing Aids will be Powered by Bose, allowing wearers to fit, program, and control their hearing aids with clinically proven, audiologist-quality results — without a doctor visit, hearing test, or prescription.

“We selected Lexie Hearing as our partner to continue to deliver our industry-redefining technology because of our shared mission to make hearing aids more accessible and affordable. Their understanding of the complex, regulated hearing aid market, and ability to reach more of the millions of people who suffer from hearing loss today was also critical to our decision,” said Nick Smith, senior vice president of Bose strategy and business development. “Bose remains committed to developing technologies and innovative experiences that improve how people hear the world around them.”

Read more: Audibel Launches AI-Enabled Hearing Aids

“This partnership with Bose represents an exciting evolution for Lexie Hearing and its commitment to making hearing healthcare accessible to everyone, everywhere,” said Nic Klopper, founder and CEO of Lexie Hearing and hearX Group. “The Lexie B1 Hearing Aids Powered byBose are one of the most revolutionary devices of its kind, marrying convenience and customer service with Bose’s groundbreaking self-fitting technology and customization. By offering top-quality products like these, especially as the FDA prepares to permit the sale of over-the-counter hearing aids this year, we will give more people control of their hearing.”

With this new partnership, BoseSoundControl™ Hearing Aids will no longer be manufactured or sold. Bose will continue to support customers who have previously purchased the product. The Lexie B1 Hearing Aids Powered by Bose will cost $899 — a fraction of the price of most traditional hearing aids — and will be available at lexiehearing.com starting today, reports BusinessWire.

About Bose Corporation

Bose Corporation was founded in 1964 by Dr.Amar G. Bose, then a professor of electrical engineering at the Massachusetts Institute of Technology. Today, the company is driven by its founding principles, investing in long-term research to develop new technologies with real customer benefits. Bose innovations have spanned decades and industries, creating and transforming categories in audio and beyond. Bose products for the home, in the car, on the go, and in public spaces have become iconic, changing the way people listen to music.

About Lexie Hearing

Lexie Hearing, developed by hearX Group, is an innovative game-changer in the U.S. hearing aid market, on a mission to make better hearing affordable and accessible to everyone. The team at Lexie is passionately committed to helping people enjoy healthy hearing without having to spend thousands of dollars, recognizing that too many people do not wear hearing aids because they are so expensive. Lexie brings a great experience to customers with high-quality hearing aids, world-class customer support, and smart technology that gives customers control of their hearing experience.

Jürgen Thalmayer
September 29, 2022

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Researchers Develop Recyclable Electronic Skin with True Flexibility

Researchers at the University of Colorado Boulder have developed a circuit board that provides...

Researchers Develop Wearable Device That Lets You Feel Cold, Heat and Pain in VR

Can you imagine being able to feel the cold of Siberia, or the heat of the desert in VR?

New Wearable to Assess Lung Function

Samay Health introduced a novel wearable that continuously analyzes lung function.

Dexcom Is Pushing Back US Launch of Its G7

After FDA voiced concerns, Dexcon delays its newest generation of the continuous glucose monitor.
Discover more